Acutus Medical Performance
| AFIBDelisted Stock | USD 0.06 0.01 15.12% |
The firm shows a Beta (market volatility) of -0.7, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Acutus Medical are expected to decrease at a much lower rate. During the bear market, Acutus Medical is likely to outperform the market. At this point, Acutus Medical has a negative expected return of -2.0%. Please make sure to confirm Acutus Medical's accumulation distribution, day typical price, and the relationship between the skewness and rate of daily change , to decide if Acutus Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Acutus Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 31.3 M |
Acutus |
Acutus Medical Relative Risk vs. Return Landscape
If you would invest 18.00 in Acutus Medical on March 14, 2024 and sell it today you would lose (12.05) from holding Acutus Medical or give up 66.94% of portfolio value over 90 days. Acutus Medical is currently does not generate positive expected returns and assumes 11.3213% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Acutus, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Acutus Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acutus Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Acutus Medical, and traders can use it to determine the average amount a Acutus Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1766
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AFIB |
Estimated Market Risk
| 11.32 actual daily | 96 96% of assets are less volatile |
Expected Return
| -2.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Acutus Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acutus Medical by adding Acutus Medical to a well-diversified portfolio.
Acutus Medical Fundamentals Growth
Acutus Stock prices reflect investors' perceptions of the future prospects and financial health of Acutus Medical, and Acutus Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Acutus Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.14 | ||||
| Operating Margin | (2.89) % | ||||
| Current Valuation | 18.75 M | ||||
| Shares Outstanding | 29.72 M | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.73 X | ||||
| Revenue | 7.16 M | ||||
| EBITDA | (13.49 M) | ||||
| Cash And Equivalents | 88.97 M | ||||
| Cash Per Share | 3.14 X | ||||
| Total Debt | 38.48 M | ||||
| Debt To Equity | 0.51 % | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (63.61 M) | ||||
| Earnings Per Share | (0.41) X | ||||
| Total Asset | 53.96 M | ||||
| Retained Earnings | (599.98 M) | ||||
About Acutus Medical Performance
To evaluate Acutus Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Acutus Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Acutus Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Acutus Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Acutus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California. Acutus Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 338 people.Things to note about Acutus Medical performance evaluation
Checking the ongoing alerts about Acutus Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Acutus Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Acutus Medical is not yet fully synchronised with the market data | |
| Acutus Medical generated a negative expected return over the last 90 days | |
| Acutus Medical has high historical volatility and very poor performance | |
| Acutus Medical has some characteristics of a very speculative penny stock | |
| Acutus Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.16 M. Net Loss for the year was (11.92 M) with loss before overhead, payroll, taxes, and interest of (15.55 M). | |
| Acutus Medical currently holds about 88.97 M in cash with (63.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Acutus Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Acutus Medical's stock is overvalued or undervalued compared to its peers.
- Examining Acutus Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Acutus Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Acutus Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Acutus Medical's stock. These opinions can provide insight into Acutus Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |